NOTE: singularity_wrapper should not be needed with the current installation as
all commands have been wrapped.

| original | translation |
|----------|-------------|
| Artificial intelligence (AI), the computerized capability of doing tasks, which until recently was thought to be the exclusive domain of human intelligence, has demonstrated great strides in the past decade. The abilities to play games, provide piloting for an automobile, and respond to spoken language are remarkable successes. How are the challenges and opportunities of medicine different from these challenges and how can we best apply these data-driven techniques to patient care and outcomes? A New England Journal of Medicine paper published in 1980 suggested that more well-defined “specialized” tasks of medical care were more amenable to computer assistance, while the breadth of approach required for defining a problem and narrowing down the problem space was less so, and perhaps, unachievable. On the other hand, one can argue that the modern version of AI, which uses data-driven approaches, will be the most useful in tackling tasks such as outcome prediction that are often difficult for clinicians and patients. The ability today to collect large volumes of data about a single individual (eg, through a wearable device) and the accumulation of large datasets about multiple persons receiving medical care has the potential to apply to the care of individuals. As these techniques of analysis, enumeration, aggregation, and presentation are brought to bear in medicine, the question arises as to their utility and applicability in that domain. Early efforts in decision support were found to be helpful; as the systems proliferated, later experiences have shown difficulties such as alert fatigue and physician burnout becoming more prevalent. Will something similar arise from data-driven predictions? Will empowering patients by equipping them with information gained from data analysis help? Patients, providers, technology, and policymakers each have a role to play in the development and utilization of AI in medicine. Some of the challenges, opportunities, and tradeoffs implicit here are presented as a dialog between a clinician (SJN) and an informatician (QZT).J Med Internet Res 2019;21(11):e16272<br/>Drs Nelson and Zeng-Treitler work together at the Biomedical Informatics Center at George Washington University. In the following we present a hypothetical dialogue which grew out of discussions they had as they considered their differing viewpoints of how artificial intelligence (AI) has developed and where it is going. While Dr Zeng-Treitler’s view of the future of AI is highly optimistic, Dr Nelson's opinion is more cautious. Dr Nelson was a practicing academic internist who became involved in informatics many years ago. He collaborated with Scott Blois on RECONSIDER (an early clinical decision support system) and on the Unified Medical Language System (UMLS) project. He eventually moved to the National Library of Medicine as Head of Medical Subject Headings. While at the National Library of Medicine, he fathered RxNorm, while continuing his work on UMLS and projects involving UMLS. Dr Zeng-Treitler has a background in computer science and obtained her PhD in medical informatics from Columbia University. She has led a number of projects in clinical data mining, natural language processing, and consumer health informatics. During the past few years, her team has been actively investigating the use of AI techniques in clinical research including development of a novel explainable deep learning approach.<br/>Dr Zeng-Treitler (The "Optimist"):<br/>After decades of promises and disappointment, thanks to the seemingly unbounded computing resources and novel, data-driven methods, AI technology has finally arrived. From Jeopardy and Siri to face identification and autonomous vehicles, data-driven approaches have made the leap from laboratory experiments to applications that are transforming our lives outside health care. In some cases, these approaches have come close to passing the Turing Test—a test of a machine’s ability to exhibit supposed human-like intelligence; machines can now perform some complex tasks such as image recognition and authentic game play as well as or better than humans would. Some would argue that the requisite approach is decidedly nonhuman. However, whatever the means to achieving these innovations, such successes have not been followed by analogous successes in health care.<br/>One dramatic example of this disparity of accomplishment is AlphaZero, a computer game engine that mastered chess, Shogi, and Go. Even before the arrival of the current generation of data-driven artifacts, chess engines have been shown to be able to play at a level superior to that of chess champions. Players of Go (a board game that is thought to be much more complex than chess), however, believed that computers were no match for high-level professionals in this game. This belief was shattered first by AlphaGo, which soundly defeated the reigning world champion of Go. Then came AlphaZero. The news is no longer that such approaches can beat the champions of Go, chess, or Shogi. Rather, the remarkable fact is that AlphaZero did not learn from human experiences and that it defeated the best prior chess engines such as Stockfish. AlphaZero triumphed by playing more games against itself than had ever been played by all human players. This is not an approach we could readily duplicate in health care.<br/>Dr Nelson (The "Cautious" One):<br/>Is winning a game, with defined rules and objectives, really the best test of human intelligence? In hindsight, the answer is “No.” For example, sophisticated chess playing programs have existed for nearly 50 years; from such programs, we learned how to organize computing resources to apply simple algorithms in a scalable way. Put differently, we did not learn anything about chess or how humans, even experts, play it. Instead, we learned that a supposed intelligence-requiring task was susceptible to a computational approach. We need to ask where and how such an approach is applicable in health care.<br/>For example, when doing tasks that are generally thought to be human and creative, can the machine recognize when it is out of its depth? Sometimes, humans have the ability to do so. However, if we can define the realm closely enough, I agree that the machines can do wonders. So, how do we define the realm?<br/>In Blois’ seminal paper on Clinical Judgment and Computers , he described the world of a physician’s thought process when seeing a patient, with the diagram shown in . Point A for a physician would be where the patient walks in the door to be seen for the first time. The nature of the complaint, the context in which the complaint occurs, and all of the myriad possibilities are present. As the problem definition moves toward Point B, a computer is better able to manage the information and knowledge necessary for high-quality care. One way in which we can think about defining the realm is that we are moving toward Point B. Some computer scientists have argued that Point A is just about managing facts, but, as Blois observed, it is more about relevance—something that has proven difficult to replicate computationally.<br/>It is indeed important to define the realm for an AI application. Many tasks in health care are much more complex than game play, and we have not witnessed the triumphs of analogous approaches in the biomedical domain as have been achieved in game play. Quite a few studies have been applying the latest deep learning technology (a key AI method) to biomedical datasets [- ]. The specific applications included image processing, natural language processing, and risk prediction. Deep learning, compared with traditional statistical and machine learning methods, has often shown modest improvements rather than breakthroughs [ - ].<br/>Whatever the details of these approaches, they apply nearly unbounded computing resources to very large amounts of data, something that has yet to happen in health care. Therefore, these approaches might prove helpful, but we do not know for sure yet.<br/>For example, a simple question posed by a colleague is beyond our current capabilities: Given a patient who starts out with a feature of metabolic syndrome, which feature of the syndrome will he or she tend to exhibit next? Simplistically, this is exactly the kind of challenge that a data-driven approach should help with, and yet, it is currently “over the horizon” due to the insufficient data that were collected in the past.<br/>Data are a key challenge when applying data-driven approaches to patient care. To begin with, biomedical data are highly complex. There many different types of data including image, text, numerical values, categorical classifications, and DNA sequences, representing tens of thousands of lab tests, procedures, diagnoses, medications, genetic markers, etc. Each data type also has its own characteristics; for example, a laboratory test value may need to be interpreted in the context of age, gender, and current conditions. However, diagnostic codes for different diseases have varying levels of accuracies.<br/>In biomedical data analysis, there is also the paradox of having too much and not enough data at the same time. On one hand, there are a tremendous amount of medical record, social media, and literature data. Efforts like the Million Veterans Project  have also collected a huge amount of DNA data. Using devices for tasks like activity tracking and continuous glucose monitoring generates more data than our current medical record systems can digest. On the other hand, the health record of a patient is an open system with much missing information in contrast with the closed system of a chess or Go game, where all data are available. Patients are observed at irregular intervals (eg, at clinic visits or during hospitalization) and are never subjected to all possible tests or treatments. Sometimes, death is the only definitive outcome.<br/>I agree that data types are multiple and complex. Simple solutions are insufficient, and the proliferation of irrelevant data in a record, not to mention the current cut-and-paste or fill-in-the-template fad, obscures what is important.<br/>One of the major difficulties with medical data is not just that it is not enough, but also that it is theory laden, that is, very few pieces of data are recorded routinely. A lot of data in observations are gathered only when the clinician has thought it is appropriate, that is, when diseases are tested for their absence or presence. If there is no reason to do the test, the test is not performed. Only a few tests are ever performed routinely; a transcribed set of physical observations (as is done in physical examination) is rarely recorded in enough detail (not to mention the failure to observe, which often occurs) to provide sufficient data for a more comprehensive analysis. For that reason alone, studies based on the recorded observations are often incomplete and potentially misleading. However, for predictions, observations not made may be the critical ones. Think about the patient with metabolic syndrome mentioned above. What data are we missing?<br/>Similarly, the results of clinical trials are not a complete picture. Even though participants have been selected, often excluding many individuals because of complicating conditions, the data collected on the participants are designed for testing certain hypotheses, with narrowly defined outcomes. A common criticism is that such trials are so artificial that they are irrelevant.<br/>The lack of integrated and standardized datasets is another issue. Although we can find many large datasets, they are often incomplete and difficult to link to other information. For example, environmental exposure, diet, physical activity, and genetic profile are among the common missing pieces of information when we examine the records about an individual patient. Detailed clinical trial datasets tend to lack long-term follow-up. Privacy issues and monetary incentives are also obstacles in data integration efforts.<br/>Real semantic interoperability to integrate and standardize datasets requires support in both terminology and how that terminology is used. Currently, human intervention is often required to interpret what one system is saying for use in another system. This situation is unfortunate; we can hope that over time, the necessary connections will take place (think of how the United States went from operator assistance on every telephone call to the automatic switching that takes place today). Such a change can only happen when many people see the need for and implement a common standard.<br/>In addition, the notion of “large” in the context of health care data is only relative. Think, instead, of many experiments undertaken by Google; if they desire, the amount of data that can be used to develop and test a model is orders of magnitude greater than that available in health care.<br/>In the domains where data-driven approaches have demonstrated success, there are outcomes that can be judged by human experts or machines themselves. For example, bilingual speakers can tell if natural language translation is working well, and the outcome of board or computer games can be easily determined. This allows easier simulation or annotation of data for machine learning. Such a task is much harder in the biomedical domains; investigation of causes or treatments of diseases in humans involve costly and long-term studies. In some cases, ethical concerns prohibit the experiments; for example, the introduction of potentially harmful genetic mutations into healthy human subjects is out of the question. We lack long-term outcome data for many treatments.<br/>I am not sure that there ever will be such a gold standard without a completely arbitrary definition. Variation between individuals is also a major obstacle. Although we perform studies using multiple subjects to account for biologic variability, our results are only approximate in their relevance to a given individual. For example, assuring genetic diversity in clinical trials is challenging, to say the least. Even the simplest tasks can be staggeringly multifactorial; for example, the information content of genetic testing for warfarin metabolism can be outweighed by whether the patient had lettuce for lunch.<br/>To expand on this observation, suppose you have an automobile that is not working appropriately. Today, you consult the sensors and the computer readout to give you very precise information about what is going wrong. The automobile has a specific design, with specific parameters that can be measured. All of the vehicles of the same year make and model can be assumed to be alike in those important aspects. It is important to realize that every human (with the exception of identical twins) is genetically unique. In that way, people are very different from automobiles or other mechanical devices. To compound the complexity with which the cause of a human problem can be addressed, what the individual experiences throughout their life is unique. Although we have nice abstractions or methods of identifying individuals who share some common characteristics (whether the presence or absence of a disease, the response or lack thereof to a medication, the similar environment, or other considerations), these are only a shorthand notation. With 7 billion persons currently living in this world, the problem appears almost open-ended. Too often in data analysis, we look at diagnostic codes as having a deep meaning. These are accepted without any recognition of the degree of uncertainty of the diagnosis. All our data may be helpful and useful, but we need to continue to view them with a large grain of salt. The fact that Google Translate works as well as it does gives us hope, but as complex as natural language translation is, it is simpler than some clinical tasks.<br/>Despite these challenges, applying data-driven approaches has the potential to transform health care. Today’s health care is labor intensive, from scheduling and triage to diagnosis and treatment. Many tasks currently undertaken by humans can be carried out by intelligent software solutions supported by sufficient data. For instance, improved voice recognition and summarization technology might help reduce the amount of time patients and clinicians spend on paperwork. Improved decision support tools ought to be able to help patients decide about the appropriateness of seeking care. An accurate assessment of short- and long-term risks and benefits will inform treatment selection and lifestyle changes.<br/>To provide another use case, there is evidence that type II diabetes may be reversible, but it is hard to apply this knowledge to an individual patient. Given the patient in front of me, what should I do, or recommend, and with what expectation? Demographics, genomics, comorbidities, psyche, competing risks, and other medications, all play a role. How, in a given person, do I reconcile all the possibilities?<br/>To develop these useful AI tools, we need better data, technology, and policy. To accumulate comprehensive, life-time data, patients must be in control and should be incentivized to share their data for research and care. Insurance, pharmaceutical, and medical institutions change over time. Currently, there are barriers for individuals to be the center of collecting the data on themselves. The barriers are present in data entry, collection, and storage; for example, some personalized health record products are tethered to an institution, while others require extensive transcribing efforts by patients or caregivers. Nevertheless, without patient consent and collaboration, gathering and linking longitudinal environmental, genetic, clinical, and behavioral data are neither feasible nor ethical. The current conditions are a huge barrier to any attempt to use data-driven approaches that have worked outside health care.<br/>Efforts including PatienstLikeMe  and the All of Us Research Project of the National Institutes of Health [ ] are examples of innovative approaches to curate bigger and better datasets. Most patients, however, are not engaged in such efforts. Patients are inherently motivated to improve their own health, but naturally have concerns regarding privacy and often do not see immediate benefits of participating in long-term studies. Appropriate incentives (eg, discounts for routine preventive care) coupled with security and authentication technologies are needed to entice a large and diverse population of patients to gather and share their data. The health care industry today owns parts of patient data and has limited motivation to purchase data from their customers. As the value of data increases, patients will become more valued as a partner.<br/>I agree that patients will need to assume the responsibility of carrying and sharing the information about themselves. However, experience tells us that not everyone is able or willing to do so. It will need cultural and political climate changes to encourage that development.<br/>When we can collect data that are not directly what the philosophers would call “theory-laden,” we may be able to refine our crude methods of patient diagnosis and care. I look forward to that day. If patients are the carrier of those data, it will be easier to obtain and use for analysis.<br/>We also need to design and implement methods specifically for handling very large and “messy” clinical data. For example, we need to understand the context of missing data and errors to get a better picture of ground truth. A lab result may be missed because there is no indication for it, practice preference, an alternative method of assessing, or a failure of data entry. Imagine how much more difficult a chess game will be, if a human player or a chess engine could only observe some squares on the board at irregular time intervals with some error or distortion of the observation.<br/>Further, we do not have an operational definition of “ground truth” in health care; a simple proposal is that one feature of ground truth is that it has predictive value—something that will be valued by clinicians and patients alike.<br/>Google has demonstrated that they can use lots of data to predict likely values for missing data in other areas ; however, it is yet to be determined whether this might work in medicine, but it is probably worth a trial. Irrespective of whether we can use large volumes of data to impute missing values, exploring how to handle the problem of absent observations is crucial, especially whenever we try to apply the results of data-driven approaches to individual patients.<br/>Another thought is that data that are missing, for any reason, are an observation in itself; the fact that the data were not obtained and recorded may be important. Think of the finding that the day and time of a test were more predictive of outcome than the result of the test . We know that the data that are missing will have some predictive value.<br/>On a different note, explanation of the data-driven models is critical to not only their adoption but also their impact . Predicting that a patient will have certain adverse events in the next several days or years is desirable. It may be argued that it is even more important to know the modifiable factors that can reduce risk and enhance outcome. Since deep learning models can be highly nonlinear, we have the opportunity to discover novel and complex patterns.<br/>I agree that explaining the prediction is critical; it is something that separates health care from, say, recognizing whether an image is a dog or a cat. However, I think you meant to say predicting a patient will probably have some adverse outcome. Nothing in life is certain except that it will end. However, we can say “it appears this behavior or finding will likely have an effect on your future” and hopefully be able to express some degree of confidence in that prediction.<br/>Learning how to express the confidence in a prediction is also important. How many folks really understand the statistics behind the predictions that occur today? What are the underlying assumptions behind any probabilistic model? It is more likely that with more frequent use and familiarity with the use of measures derived for AI models will lead to their acceptance.<br/>I agree. These are all steps to be taken in order to optimize the use of big data through AI to improve medical care.<br/>As a parting thought, we need to be cautious about how intrusive data-driven approaches might be in the care process. Although McDonald  demonstrated that performance in care improves with reminders [ ], the later experience has been one of too many reminders, leading to alert fatigue. When caregivers choose to override and ignore helpful information because of overload, have we accomplished anything?<br/>I hope that careful design of systems and consideration of clinical workflow will alleviate the problem of excessive intrusiveness. Although it is tempting to just “let AI do it,” the recent experiences with the Boeing 737 MAX demonstrate that there is danger in doing so. Neither AI nor a pilot alone is the optimal strategy in flying. In health care, involving patients more extensively in their care, together with AI and providers, may ultimately be an approach that works.<br/>Conflicts of Interest<br/>- Blois MS. Clinical Judgment and Computers. N Engl J Med 1980 Jul 24;303(4):192-197. [CrossRef]<br/>- Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform 2018 Nov 27;19(6):1236-1246 [FREE Full text] [CrossRef] [Medline]<br/>- Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS ONE 2017 Apr 4;12(4):e0174944. [CrossRef]<br/>- Miotto R, Li L, Kidd BA, Dudley JT. Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records. Sci Rep 2016 May 17;6(1):26094 [FREE Full text] [CrossRef] [Medline]<br/>- Quach K. The register. 2019. IBM Watson Health cuts back drug discovery 'artificial intelligence' after lackluster sales URL: https://www.theregister.co.uk/2019/04/18/ibm_watson_health [accessed 2019-10-23]<br/>- Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, et al. Scalable and accurate deep learning with electronic health records. NPJ Digit Med 2018 May 8;1(1):18 [FREE Full text] [CrossRef] [Medline]<br/>- Lee J, Jun S, Cho Y, Lee H, Kim GB, Seo JB, et al. Deep Learning in Medical Imaging: General Overview. Korean J Radiol 2017;18(4):570. [CrossRef]<br/>- U.S Department of Veterans Affairs. Million Veteran Program (MVP) URL: https://www.research.va.gov/mvp/ [accessed 2019-10-23]<br/>- Patientslikeme. URL: https://www.patientslikeme.com [accessed 2019-10-23]<br/>- All of Us Research Program. URL: https://allofus.nih.gov [accessed 2019-10-23]<br/>- Halevy A, Norvig P, Pereira F. The unreasonable effectiveness of data. IEEE Intell Syst 2009 Mar;24(2):8-12. [CrossRef]<br/>- Agniel D, Kohane IS, Weber GM. Biases in electronic health record data due to processes within the healthcare system: retrospective observational study. BMJ 2018 Apr 30:k1479. [CrossRef]<br/>- Holzinger A, Langs G, Denk H, Zatloukal K, Müller H. Causability and explainabilty of artificial intelligence in medicine. WIREs Data Mining Knowl Discov 2019 Apr 02:e1312. [CrossRef]<br/>- McDonald CJ. Protocol-Based Computer Reminders, the Quality of Care and the Non-Perfectibility of Man. N Engl J Med 1976 Dec 09;295(24):1351-1355. [CrossRef]<br/>&#124;AI: artificial intelligence&#124;<br/>&#124;UMLS: Unified Medical Language System&#124;<br/>Edited by G Eysenbach; submitted 15.09.19; peer-reviewed by A Holzinger; comments to author 14.10.19; revised version received 15.10.19; accepted 20.10.19; published 27.11.19Copyright<br/>©Qing Zeng-Treitler, Stuart J Nelson. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 27.11.2019.<br/>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included. | Léirigh intleacht shaorga (AI), an cumas ríomhairithe maidir le tascanna a dhéanamh, a measadh go dtí le déanaí gurb é an fearann eisiach faisnéise daonna é, go mór le deich mbliana anuas. Is maith an cumas chun cluichí a imirt, píolótach a sholáthar do gluaisteán, agus freagra a thabhairt ar theanga labhartha. Conas atá dúshláin agus deiseanna míochaine difriúil ó na dúshláin seo agus conas is fearr is féidir linn na teicnící sonraí-tiomáinte seo a chur i bhfeidhm ar chúram agus ar thorthaí othar? Eisíodh páipéar nua Sasanach Leighis a foilsíodh sa bhliain 1980 gurbh acmhainn níos fearr a bhí i gceist le cúram leighis, agus ba lú an méid cur chuige a bhí ag teastáil chun fadhb a shainiú agus an spás fadhbanna a chúngú, agus b’fhéidir, nárbh fhéidir a bhaint amach. Ar an láimh eile, is féidir a mhaíomh go mbeidh leagan nua-aimseartha AI, a úsáideann cineálacha cur chuige atá bunaithe ar shonraí, an ceann is úsáidí chun dul i ngleic le tascanna ar nós tuar torthaí a bhíonn deacair go minic do chlinicí agus d'othair. Tá sé de chumas ag an gcumas sa lá atá inniu ann líon mór sonraí a bhailiú faoi dhuine aonair (mar shampla, trí ghléas inchaite) agus sonraí móra a charnadh maidir le líon mór daoine a fhaigheann cúram leighis chun aire a thabhairt do dhaoine aonair. Ós rud é go dtugtar na teicnící anailíse, ríomh-áirimh, comhshuimithe agus cur i láthair seo le fios i gcúrsaí leighis, tagann an cheist chun cinn maidir lena gcumas agus lena infheidhmeacht sa réimse sin. Fuarthas go raibh na hiarrachtaí luatha i dtacaíocht cinneadh cabhrach; de réir mar a bhí na córais thar a bheith tairbheach, léirigh taithí níos déanaí deacrachtaí ar nós tuirse foláirimh agus sruthán dochtúir níos forleithne. An dtiocfaidh rud éigin cosúil leis seo ó réamh-mheastacháin tiomáinte sonraí?An dtabharfaidh sé cumhacht d’othair trí fhaisnéis a fuarthas ó chabhair anailíse sonraí a sholáthar dóibh? Tá ról ag othair, soláthraithe, teicneolaíocht agus lucht déanta beartas gach ceann acu i bhforbairt agus in úsáid IS sa leigheas. Cuirtear cuid de na dúshláin, na deiseanna agus na saoirsí atá intuigthe anseo i láthair mar chomhphlé idir cliniceoir (SJN) agus fear gnó (QZT).<br/>Oibríonn na Dr. Nelson agus Zen-Trianer le chéile ag an Ionad Faisnéisíochta Bithleighis in Ollscoil George Washington. Ina dhiaidh sin, chuireamar agallamh hipitéiseach i láthair a d’fhás as plé agus iad ag smaoineamh ar a gcuid tuairimí difriúla faoi conas a d’fhorbair an intleacht shaorga (AI) agus cén áit a bhfuil sé ag dul. Cé go bhfuil dearcadh an Dr Zeng-Trianer ar thodhchaí IS an-dóchasach, tá tuairim an Dr Nelson níos cúramach. Ba é an Dr Nelson go raibh baint acu le léirithe le blianta fada ó shin. D’oibrigh sé le Scott Blois on RECODER (córas tacaíochta do chinneadh cliniciúil) agus leis ar an tionscadal Córas na dTeangacha Míochaine Aontaithe (UMLS). Bhog sé ar deireadh thiar go dtí Leabharlann Náisiúnta an Leighis mar Cheannteidil Ábhair Leighis. Agus é ag Leabharlann Náisiúnta na Míochaine, d’athair sé RxNrm, agus ag leanúint ar aghaidh lena chuid oibre ar UMLS agus ar thionscadail a bhaineann le UMLS. Tá cúlra san eolaíocht ríomhaireachta ag an Dr Zeng-Tler agus fuair sé a PhD in eolas leighis ó Ollscoil Columbia. Tá roinnt tionscadal faoi stiúir sí i mianadóireacht sonraí cliniciúla, próiseáil teanga nádúrtha, agus faisnéis sláinte tomhaltóirí. Le cúpla bliain anuas, tá a foireann ag déanamh imscrúdú gníomhach ar úsáid teicnící IS sa taighde cliniciúil lena n-áirítear forbairt cur chuige foghlama domhain soiléir.<br/>An Dr Zeng-Triper (An "Optaim"):<br/>Tar éis blianta fada de geallúintí agus díomá, a bhuíochas leis na hacmhainní ríomhaireachta agus leis an úrscéal gan bhunús, tá teicneolaíocht AI tar éis teacht ar deireadh. Ó Josephy agus Siri go aghaidh ar aithint agus feithiclí uathrialacha, rinne cur chuige sonraí-tiomáinte an léim ó thurgnaimh saotharlainne go hiarratais a a athraíonn ár saol lasmuigh de chúram sláinte. I gcásanna áirithe, tá na cineálacha cur chuige seo gar don Tástáil Tturing a rith - tástáil ar chumas meaisín faisnéis atá ceaptha ag an duine a thaispeáint; is féidir le meaisíní roinnt tascanna casta a dhéanamh anois mar aitheantas íomhá agus imirt cluiche barántúla chomh maith le níos fearr ná mar a bheadh daoine. Bheadh roinnt a mhaíomh go bhfuil an cur chuige riachtanach cinnte neamh-dhaonna., Mar sin féin, is cuma cad iad na bealaí chun na nuálaíochtaí seo a bhaint amach, níor éirigh rath den sórt sin ina dhiaidh mar thoradh ar an rath céanna ar chúram sláinte.<br/>Sampla drámatúil amháin de seo a nochtadh i gcrích tá AlphaZero, inneall cluiche ríomhaire go bhfuil máistreacht fichille, Shogi, agus Go. Fiú sular tháinig an ghlúin atá ann faoi láthair de artifacts-tiomáinte, tá innill fichille léirithe a bheith in ann a imirt ar leibhéal níos fearr ná leibhéal na Seaimpíní fichille. Rannpháirtithe Go (cluiche boird go meastar a bheith i bhfad níos casta ná fichille), áfach, nach raibh ríomhairí aon chluiche do ghairmithe ard-leibhéal sa chluiche seo. Chuir AlfaGo an creideamh seo isteach ar dtús, rud a d’fhág go raibh curadh domhanda ag dul i léig. Ansin tháinig AlphaZero amach a thuilleadh gur féidir leis na cineálacha cur chuige sin dul i ngleic le seaimpíní Téigh, fichille nó Shogi. Ina ionad sin, is é an bhfíric iontach nach raibh AlfaZero fhoghlaim ó thaithí an duine agus go defeated sé na hinnill fichille is fearr roimh ré ar nós Stockfish. AlphaZero bua ag imirt cluichí níos mó i gcoinne féin ná mar a bhí riamh bhí ag gach imreoirí daonna. Ní cur chuige é seo a d’fhéadfaimis a dhúbailt go héasca i gcúram sláinte.<br/>An Dr Nelson (An "Baintiúil" Amháin):<br/>An bhfuil a bhuaigh cluiche, le rialacha agus cuspóirí sainithe, i ndáiríre an tástáil is fearr ar intleacht an duine? I bac, is é an freagra "Níl. Mar shampla, tá cláir sofaisticiúla ag imirt fichille ann le beagnach 50 bliain; ó na cláir sin, d'fhoghlaim muid conas acmhainní ríomhaireachta a eagrú a chur i bhfeidhm halgartaim simplí ar bhealach inscálaithe. Cuir ar bhealach difriúil, ní raibh muid ag foghlaim aon rud faoi fichille nó conas a bhí daoine, fiú saineolaithe, é a imirt., Ina ionad sin, d'fhoghlaim muid go raibh tasc-riachtanach ceaptha a bhí so-ghabhálach le cur chuige ríomhaireachta. Ní mór dúinn iarraidh ar an áit agus ar an gcaoi a bhfuil cur chuige den sórt sin infheidhme i gcúram sláinte.<br/>Mar shampla, nuair a bhíonn tascanna a mheastar go ginearálta a bheith daonna agus cruthaitheach, is féidir leis an meaisín a aithint nuair a bhíonn sé as a doimhneacht? Uaireanta, tá an cumas ag daoine é sin a dhéanamh. Mar sin féin, más féidir linn an réimse a shainiú go dlúth go leor, aontaím gur féidir leis na meaisíní iontais a dhéanamh. Mar sin, conas a shainmhínímid an réimse?<br/>Rinne sé cur síos ar shaol an phróisis smaoinimh dochtúra agus othar á fheiceáil aige, an léaráid a thaispeántar i mBlois ar Bhreithiúnas agus Ríomhairí Cliniciúla. Pointe A a bheadh ann do dhochtúir nuair a bhíonn an t-othar ag siúl sa doras le feiceáil den chéad uair.An cineál gearáin, an comhthéacs ina bhfuil an gearán, agus na féidearthachtaí iomadúla go léir i láthair. De réir mar a ghluaiseann an sainmhíniú fadhbanna i dtreo Pointe B, is fearr ríomhaire in ann an fhaisnéis agus an t-eolas is gá a bhainistiú le haghaidh cúram ardchaighdeáin. Bealach amháin inar féidir linn smaoineamh ar an réimse a shainmhíniú ná go bhfuil muid ag bogadh i dtreo Pointe B. Roinnt eolaithe ríomhaireachta a d'áitigh go bhfuil Pointe A díreach faoi fíricí a bhainistiú, ach, de réir mar a thugtar faoi deara Blosi, baineann sé níos mó le hábhar - rud a d'fhéadfadh a bheith deacair a mhacasamhlú go ríomhaireachta.<br/>Tá sé tábhachtach go deimhin a shainmhíniú ar an réimse le haghaidh iarratas IS.Tá go leor tascanna i gcúram sláinte i bhfad níos casta ná an cluiche a imirt, agus ní mór dúinn a fhianú an bua cur chuige cosúil leis an réimsecheannais mar a bhí bainte amach i imirt cluiche. Tá roinnt staidéir déanta go leor chun an teicneolaíocht foghlama dhomhain is déanaí (modh AI) a chur i bhfeidhm maidir le tacar sonraí bithleighis [...] Áiríodh leis na feidhmchláir shonracha próiseáil íomhá, próiseáil teanga nádúrtha, agus tuar riosca. Is minic a léirigh foghlaim dhomhain, i gcomparáid le modhanna traidisiúnta foghlama agus meaisín, feabhsúcháin measartha seachas dul chun cinn [...]<br/>Cibé rud a bhaineann le sonraí na gcur chuige seo, baineann siad le beagnach gan teorainn acmhainní ríomhaireachta a chur ar fáil do mhéideanna móra sonraí, rud nach bhfuil fós le tarlú i gcúram sláinte.Dá bhrí sin, d'fhéadfadh na cineálacha cur chuige seo a bheith cabhrach, ach níl a fhios againn go cinnte go fóill.<br/>Mar shampla, tá ceist shimplí a bhaineann le comhghleacaí níos faide ná ár gcumais reatha: I bhfianaise othar a thosaíonn amach le gné de siondróm meitibileach, cén ghné den siondróm a gcaithfidh sé nó sí a thaispeáint amach romhainn? Go bunúsach, is é seo an cineál dúshláin ba cheart do chur chuige sonraí-tiomáinte cabhrú leis, agus fós, tá sé faoi láthair "os cionn na spéire" mar gheall ar na sonraí neamhleor a bailíodh san am atá caite.<br/>Is dúshlán mór iad sonraí agus cur chuige á chur i bhfeidhm maidir le cúram othar. Chun tús a chur le sonraí briogóideacha, tá sonraí an-chasta. Tá go leor cineálacha éagsúla sonraí ann lena n-áirítear íomhá, téacs, luachanna uimhriúla, aicmiúchán catagóiriúil, agus seicheamh DNA, a léiríonn na mílte tástáil saotharlainne, nósanna imeachta, diagnóisí, cógais, marcóirí géiniteach, srl. Tá a saintréithe féin ag gach cineál sonraí freisin; mar shampla, d’fhéadfadh go mbeadh gá le luach tástála saotharlainne a léiriú i gcomhthéacs aois, inscne agus coinníollacha reatha.Mar sin féin, tá leibhéil éagsúla cruinnis ag cóid dhiagnóiseacha i gcás galar éagsúla.<br/>San anailís sonraí bithmhéadracha, tá paradox ann freisin chun an iomarca sonraí a bheith agat agus ní leor sonraí a bheith ag an am céanna.Ar láimh amháin, tá méid ollmhór taifead míochaine, na meáin shóisialta agus sonraí litríochta ann. Tá méid ollmhór sonraí bailithe ag hiarrachtaí cosúil le Tionscadal Vernas Milliún freisin.Úsáid feistí le haghaidh tascanna cosúil le rianú gníomhaíochta agus gineann monatóireacht ghlúcós leanúnach níos mó sonraí ná ár gcórais taifead leighis reatha is féidir a dhíleá. Ar an láimh eile, is córas oscailte é taifead sláinte othar a bhfuil a lán faisnéise ar iarraidh i gcodarsnacht leis an gcóras dúnta de fichille nó Beir cluiche, i gcás go bhfuil na sonraí go léir ar fáil. Tugtar faoi deara go mbíonn na hothair ag eatraimh neamhrialta (m.sh. cuairteanna cliniciúla nó le linn ospidéal) agus ní chuirtear iad riamh faoi réir gach tástáil nó cóireáil a d’fhéadfadh a bheith ann uaireanta, is é an bás an t-aon toradh cinntitheach.<br/>Aontaíonn mé go bhfuil cineálacha sonraí il agus casta.Tá réitigh shimplí neamhleor, agus iomadú sonraí neamhábhartha i dtaifead, gan trácht ar an fad atá ann faoi láthair nó an fad-i-teimpléad a líonadh, doiléir cad atá tábhachtach.<br/>Ceann de na deacrachtaí móra le sonraí leighis ní hamháin nach leor é, ach freisin go bhfuil sé luchtaithe teoirice, is é sin, is beag píosa sonraí a thaifeadtar go rialta. Ní bhailítear go leor sonraí i mbreathnóireacht ach amháin nuair a shíl an cliniceoir go bhfuil sé cuí, is é sin, nuair a dhéantar tástáil ar ghalair as a n-éagmais nó as a láithreacht.Mura bhfuil cúis ar bith ann chun an tástáil a dhéanamh, ní dhéantar an tástáil. Ní dhéantar ach cúpla tástáil go rialta; is annamh a thaifeadtar tacar tras-scríofa de bhreathnóirí fisiciúla (mar a dhéantar i scrúdú fisiceach) go mion (gan trácht ar an mainneachtain breathnú air, rud a tharlaíonn go minic) chun sonraí leordhóthanacha a sholáthar le haghaidh anailíse níos cuimsithí. Ar an ábhar sin amháin, is minic a bhíonn staidéir atá bunaithe ar na breathnóireachtaí taifeadta neamhiomlán agus a d’fhéadfadh a bheith míthreorach, áfach, i gcás tuar, ní féidir gurb iad breathnuithe a rinneadh na cinn criticiúla. Smaoinigh ar an othar le siondróm meitibileach a luaitear thuas. Cad iad na sonraí atá á iarraidh againn?<br/>Ar an gcaoi chéanna, ní pictiúr iomlán iad torthaí trialacha cliniciúla. Cé gur roghnaíodh rannpháirtithe, is minic a eisiann siad go leor daoine aonair mar gheall ar choinníollacha casta, tá na sonraí a bhailítear chun hipitéisí áirithe a thástáil, le torthaí atá sainithe go cúng. Is léir ó léirmheastóirí coitianta go bhfuil a leithéid de thrialacha chomh saorga go bhfuil siad neamhábhartha.<br/>Is ceist eile é an easpa tacar sonraí comhtháite agus caighdeánaithe.Cé gur féidir linn teacht ar go leor tacar sonraí móra, is minic a bhíonn siad neamhiomlán agus deacair nasc a dhéanamh le faisnéis eile. Mar shampla, tá nochtadh comhshaoil, aiste bia, gníomhaíocht fhisiceach, agus próifíl ghéiniteach i measc na bpíosaí faisnéise coitianta nuair a scrúdaímid na taifid faoi othar aonair. Tá fadhbanna príobháideachta agus dreasachtaí airgeadaíochta ina mbacainní freisin ar iarrachtaí maidir le comhtháthú sonraí.<br/>Teastaíonn tacaíocht ó idir-inoibritheacht shéimeantach fíor chun tacair sonraí a chomhtháthú agus a chaighdeánú sa téarmaíocht agus sa chaoi a n-úsáidtear an téarmaíocht sin faoi láthair, is minic a bhíonn gá le hidirghabháil an duine chun a léirmhíniú cén córas amháin atá ag rá lena úsáid i gcóras eile. Tá an staid seo trua; is féidir linn a bheith ag súil go mbeidh na naisc is gá ar siúl le himeacht ama (smaoineamh ar conas a chuaigh na Stáit Aontaithe as cúnamh oibreoir ar gach glao teileafóin ar an lascadh uathoibríoch a tharlaíonn inniu). Ní féidir athrú den sórt sin a tharlóidh ach amháin nuair a fheiceann go leor daoine an gá atá le caighdeán coiteann agus é a chur i bhfeidhm.<br/>Ina theannta sin, níl an coincheap de “mhór” i gcomhthéacs sonraí cúram sláinte ach coibhneasta. Smaoinigh, ina ionad sin, ar go leor turgnamh a rinne Google; más mian leo, is é an méid sonraí is féidir a úsáid chun samhail a fhorbairt agus a thástáil ná orduithe méide níos mó ná an méid atá ar fáil i gcúram sláinte.<br/>Sna réimsí ina bhfuil rath léirithe ag cur chuige atá tiomáinte ag sonraí, tá torthaí ann ar féidir le saineolaithe nó meaisíní daonna iad féin a mheas. Mar shampla, is féidir le cainteoirí dátheangacha insint an bhfuil an t-aistriúchán teanga nádúrtha ag obair go maith, agus is féidir toradh an bhoird nó na gcluichí ríomhaireachta a chinneadh go héasca. Tá a leithéid de thasc i bhfad níos deacra sna réimsí bithleighis; fiosrú cúiseanna nó cóireálacha galar i ndaoine a bhfuil staidéir costasacha agus fadtéarmacha i gceist leo. I gcásanna áirithe, cuireann imní eiticiúla cosc ar na turgnaimh; mar shampla, tá tabhairt isteach sócháin a d’fhéadfadh a bheith díobhálach do dhaoine is ábhar sláintiúil.<br/>Níl mé cinnte go mbeidh a leithéid de chaighdeán óir ann riamh gan sainmhíniú go hiomlán treallach.Is bac mór é idirdhealú idir daoine aonair freisin. Cé go ndéanaimid staidéir ag baint úsáide as ábhair éagsúla chun aird a thabhairt ar éagsúlacht bhitheolaíochta, níl ár dtorthaí thart ach amháin mar a bhaineann siad le duine aonair ar leith, mar shampla, ag cinntiú go bhfuil éagsúlacht ghéiniteach i dtrialacha cliniciúla dúshlánach, chun an méid is lú a rá. Is féidir fiú na tascanna is simplí a bheith ina ardánach; mar shampla, is féidir an t-ábhar faisnéise a bhaineann le tástáil ghéiniteach ar mheitibileacht chogaidh a shárú cibé an raibh leitís ag an othar don lón.<br/>Chun leathnú ar an tuairim seo, is dócha go bhfuil gluaisteán agat nach bhfuil ag obair go cuí.Sa lá atá inniu ann, téann tú i gcomhairle leis na braiteoirí agus leis an léamh ríomhaire chun faisnéis an-chruinn a thabhairt duit faoi cad atá ag dul mícheart. Tá dearadh ar leith ag an gluaisteán, le paraiméadair ar leith is féidir a thomhas., Gach ceann de na feithiclí na bliana céanna a dhéanamh agus is féidir múnla a ghlacadh chun a bheith cosúil leis na gnéithe tábhachtacha sin. Tá sé tábhachtach a thuiscint go bhfuil gach duine (ach amháin cúpla comhionann) uathúil go géiniteach. Ar an mbealach sin, tá daoine an-difriúil ó ghluaisteáin nó ó ghléasanna meicniúla eile. Chun an chastacht ar féidir aghaidh a thabhairt uirthi mar chúis le fadhb an duine, is uathúil an taithí aonair ar feadh a saoil. Cé go bhfuil astógálacha nó modhanna deasa againn chun daoine aonair a aithint a bhfuil tréithe comónta acu (cibé acu galar a bheith i láthair nó gan bheith i láthair, an fhreagairt nó an easpa cógais, an timpeallacht chéanna, nó cúrsaí eile), níl iontu seo ach nodaireacht ghearr. Le 7 mbilliún duine ina gcónaí sa saol seo faoi láthair, is cosúil go bhfuil an fhadhb beagnach oscailte, ró-mhinic in anailís sonraí, táimid ag féachaint ar chóid dhiagnóiseach mar bhrí dhomhain. Glactar leis na sonraí seo gan aitheantas a fháil ar chéim na neamhchinnteachta a bhaineann leis an diagnóis. D'fhéadfadh ár gcuid sonraí go léir a bheith cabhrach agus úsáideach, ach ní mór dúinn leanúint ar aghaidh ag féachaint orthu le gráin mór salainn. Ós rud é go n-oibríonn Google Translate chomh maith le go dtugann sé dóchas dúinn, ach chomh casta agus atá aistriúchán teanga nádúrtha, tá sé níos simplí ná roinnt tascanna cliniciúla.<br/>In ainneoin na ndúshlán seo, tá sé de chumas ag cur chuige atá tiomáinte ag sonraí cúram sláinte a athrú.Is é cúram sláinte an lae inniu ná dianobair, ó sceidealú agus trí chéile chun diagnóis agus cóireáil a dhéanamh. Is féidir go leor tascanna a dhéanann daoine faoi láthair a dhéanamh trí réitigh bhogearraí cliste a fhaigheann tacaíocht ó shonraí leordhóthanacha. Mar shampla, d'fhéadfadh aitheantas guth níos fearr agus teicneolaíocht achoimre feabhsaithe cabhrú leis an méid ama a chaitheann othair agus clinicí ar pháipéarachas a laghdú. Ba cheart go mbeadh uirlisí tacaíochta cinnteoireachta feabhsaithe in ann cabhrú le hothair cinneadh a dhéanamh faoi oiriúnacht an chúraim a lorg.Cuirfidh measúnú cruinn ar rioscaí agus sochair ghearrthéarmacha fadtéarmacha an rogha cóireála agus athruithe ar stíl mhaireachtála ar an eolas.<br/>Chun cás úsáide eile a sholáthar, tá fianaise ann go bhféadfadh diaibéiteas cineál II a bheith inchúlaithe, ach tá sé deacair an t-eolas seo a chur i bhfeidhm ar othar aonair.Mar gheall ar an othar os mo chomhair, cad ba cheart dom a dhéanamh, nó a mholadh, agus cén ionchas atá agam? Cén ról a bhíonn ag déimeagrafaic, genomics, cobrities, psyche, rioscaí iomaíocha, agus cógais eile, go léir.Conas, i duine ar leith, an féidir liom réiteach a fháil ar na féidearthachtaí go léir?<br/>Chun na huirlisí úsáideacha AI seo a fhorbairt, teastaíonn sonraí, teicneolaíocht agus beartas níos fearr uainn. Chun sonraí cuimsitheacha, saolré a charnadh, ní mór d’othair a bheith i gceannas agus ba cheart iad a spreagadh chun a gcuid sonraí a roinnt le haghaidh taighde agus cúraim. Athraíonn árachas, cógaisíocht agus institiúidí leighis le himeacht ama.Faoi láthair, tá bacainní ann do dhaoine aonair a bheith i lár na sonraí a bhailiú orthu féin. Tá na bacainní i láthair in iontráil, i mbailiú agus i stóráil sonraí; mar shampla, tagraítear roinnt táirgí taifead sláinte pearsantaithe do institiúid, agus éilíonn cuid eile iarrachtaí forleathan tras-scríofa ó othair nó ó chúramóirí. Mar sin féin, gan toiliú na n-othar agus comhoibriú, ní féidir sonraí fadaimseartha, géiniteach, cliniciúla agus iompraíochta a bhailiú agus a nascadh. Tá na coinníollacha reatha ina mbacainn ollmhór ar aon iarracht cur chuige sonraí a úsáid a d’oibrigh lasmuigh de chúram sláinte.<br/>Samplaí de chuirí nuálacha iad na hiarrachtaí lena n-áirítear OtharsalikeMe agus Tionscadal Taighde na nInstitiúidí Náisiúnta Sláinte [] chun tacair sonraí níos mó agus níos fearr a choimeád, áfach, níl formhór na n-othar rannpháirteach sna hiarrachtaí sin. Spreagtar go bunúsach othair chun a sláinte féin a fheabhsú, ach go nádúrtha bíonn imní orthu maidir le príobháideachas agus go minic ní fheiceann siad buntáistí láithreacha a bhaineann le páirt a ghlacadh i staidéir fhadtéarmacha. Tá dreasachtaí iomchuí (m.sh. lascainí do ghnáthchúram coisctheach) in éineacht le teicneolaíochtaí slándála agus fíordheimhnithe de dhíth chun líon mór othar a mhealladh chun a gcuid sonraí a bhailiú agus a roinnt. Is leis an tionscal cúraim sláinte atá cuid de shonraí othar sa lá atá inniu ann agus tá spreagadh teoranta aige chun sonraí a cheannach óna gcustaiméirí.Mar an luach a mhéadaíonn sonraí, beidh níos mó luach na n-othar ag baint leis mar chomhpháirtí.<br/>Aontaím go mbeidh ar othair freagracht a ghlacadh as an bhfaisnéis fúthu féin a iompar agus a roinnt. Mar sin féin, insíonn taithí dúinn nach bhfuil gach duine in ann nó sásta é sin a dhéanamh. Beidh athruithe cultúrtha agus polaitiúla ag teastáil chun an fhorbairt sin a spreagadh.<br/>Nuair is féidir linn sonraí a bhailiú nach iad go díreach a ghlaofadh na fealsamh “theoir-ladaithe,” b’fhéidir go mbeimid in ann ár modhanna díograiseacha maidir le diagnóis agus cúram othar a bheachtú. Táim ag tnúth leis an lá sin. Má tá othair an t-iompróir de na sonraí sin, beidh sé níos éasca a fháil agus a úsáid le haghaidh anailíse.<br/>Ní mór dúinn freisin modhanna a dhearadh agus a chur i bhfeidhm go sonrach le haghaidh láimhseáil sonraí cliniciúla an-mhór agus "messy" Mar shampla, ní mór dúinn a thuiscint ar an gcomhthéacs sonraí agus earráidí ar iarraidh a fháil pictiúr níos fearr de fhírinne na talún. Féadfar toradh saotharlainne a chailleadh toisc nach bhfuil aon léiriú ann maidir leis, rogha cleachtais, modh eile measúnaithe, nó mainneachtain sonraí. Samhlaigh cé mhéad níos deacra a bheidh cluiche fichille a bheith, más rud é nach bhféadfaí imreoir daonna nó inneall fichille ach breathnú ar roinnt cearnóga ar an mbord ag eatraimh neamhrialta am le earráid nó saobhadh ar an tuairim.<br/>Ina theannta sin, níl sainmhíniú oibríochta againn ar ‘fís talún’ i gcúram sláinte; is éard atá i gceist le togra simplí ná gné amháin den fhírinne talún go bhfuil luach réamh-mheasta aige—rud a bheidh luacháil ag cliniceoirí agus othair araon.<br/>Tá sé léirithe ag Google gur féidir leo go leor sonraí a úsáid chun luachanna dóchúla a thuar maidir le sonraí a bheith ar iarraidh i réimsí eile; áfach, tá sé fós le cinneadh an bhféadfadh sé seo oibriú i gcúrsaí leighis, ach is dócha gur fiú triail é. Is cuma cé acu is féidir linn méideanna móra sonraí a úsáid chun luachanna atá ar iarraidh a chur i bhfeidhm, tá sé ríthábhachtach iniúchadh a dhéanamh ar conas fadhb na breathnóireachta as láthair a láimhseáil, go háirithe aon uair a dhéanaimid iarracht torthaí cur chuige sonraí-tiomáinte a chur i bhfeidhm maidir le hothair aonair.<br/>Smaoineamh eile ná go bhfuil na sonraí atá in easnamh, ar chúis ar bith, ina tuairim ann féin; d'fhéadfadh sé go mbeadh tábhacht leis na sonraí nach bhfuarthas agus nár taifeadadh iad. Smaoinigh ar an gcinneadh go raibh an lá agus an t-am tástála níos réamh-mheasta de thoradh na tástála.Tá a fhios againn go mbeidh roinnt luach thuar ag na sonraí atá ar iarraidh.<br/>Ar nóta difriúil, tá sé ríthábhachtach míniú a thabhairt ar na samhlacha sonraí-tiomáinte a ghlacadh ní amháin ach a dtionchar freisin.Tairithe go mbeidh imeachtaí díobhálacha áirithe ag othar sna laethanta nó blianta amach romhainn. D'fhéadfaí a mhaíomh go bhfuil sé níos tábhachtaí fós eolas a fháil ar na fachtóirí modhnúcháin is féidir a laghdú riosca agus toradh a fheabhsú. Ós rud é gur féidir le samhlacha domhain foghlama a bheith an-níosach, ní mór dúinn an deis a fháil amach patrúin nua agus casta.<br/>Aontaím go bhfuil sé ríthábhachtach an tuar a mhíniú; is rud é a scarann cúram sláinte as, a rá, ag aithint an bhfuil íomhá ina mhadra nó ina cat., Mar sin féin, is dóigh liom go mbeidh toradh díobhálach ag othar a thuar. Níl aon rud sa saol áirithe ach amháin go dtiocfaidh deireadh leis, áfach, is féidir linn a rá “is cosúil go mbeidh tionchar ag an iompar nó an cinneadh seo ar do thodhchaí” agus tá súil againn go mbeidh sé in ann méid áirithe muiníne a chur in iúl sa tuar sin.<br/>Tá sé tábhachtach freisin foghlaim conas an mhuinín a chur in iúl i tuar.Conas a thuigeann go leor daoine na staitisticí atá taobh thiar de na tuartha a tharlaíonn inniu? Cad iad na toimhdí bunúsacha atá taobh thiar d'aon mhúnla dóchúil? Is é is dóichí go n-eascróidh glacadh leo le húsáid níos minice agus cur amach ar úsáid na mbeart a dhíorthaítear do mhúnlaí AI.<br/>Aontaím. Tá na céimeanna seo go léir le glacadh chun úsáid sonraí móra a bharrfheabhsú trí IS chun cúram leighis a fheabhsú.<br/>Mar chuid den tuairim gur gá dúinn a bheith aireach faoi conas a d’fhéadfadh cur chuige intrustracha maidir le sonraí a bheith sa phróiseas cúraim. Cé gur léirigh McDonald go bhfeabhsaíonn an fheidhmíocht i gcúram le meabhrúcháin [], tá an taithí níos déanaí ar cheann den iomarca meabhrúcháin, rud a fhágann go gcuirfí tuirse ar an airdeall. Nuair a roghnaíonn cúramóirí faisnéis chuiditheach a shárú agus neamhaird a dhéanamh de bharr ró-ualú, ní mór dúinn aon rud a chur i gcrích?<br/>Tá súil agam go maolófar dearadh cúramach córas agus breithniú ar shreabhadh oibre cliniciúil an fhadhb atá i gceist maidir le hintreallús iomarcach. Cé go bhfuil sé tempting go díreach "lig AI é a dhéanamh," an taithí le déanaí leis an Boeing 737 MAX léiríonn go bhfuil baol ann.Ní AI ná píolótach ina n-aonar is é an straitéis is fearr is féidir ag eitilt. I gcúram sláinte, a bhaineann le hothair níos forleithne ina gcúram, mar aon le AI agus soláthraithe, d’fhéadfadh sé gur cur chuige é i ndeireadh na dála a oibríonn.<br/>Coimhlintí Suime<br/>- Blois MS Judge agus Ríomhairí cliniciúla. N. English J Med 1980;303(4):192-1997. [CrosRef]<br/>- Mitito R, Wang F, Wang S, Jiang X, Dudley JT. Foghlaim dhomhain do chúram sláinte: athbhreithniú, deiseanna agus dúshláin.<br/>- Weng SFT, Reps J, Kai J, Garibaldi J, Qurshi N. Is féidir le meaisín-fhoghlaim feabhas a chur ar thuar riosca cardashoithíoch ag baint úsáide as sonraí cliniciúla ghnáthamh?<br/>- Mitito R, Li, Kid BA, Dudeley JT.: Ionadaí domhain gan mhaoirseacht chun Todhchaí na nOthair a thuar ó na Taifid Sláinte Leictreonach. Freagra 1 Bealtaine 2016; 6 (1):2604 [CrosRef]<br/>- Quach K. The clár.2019 Gearrann sláinte IBM Watson ‘fuaireolas saorga’ ar ais tar éis díolacháin línitheoir URL: https://www.theregister.co.uk/2019/04/18/imb_watson_health [rochtaine10-23]<br/>- Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hard M, et al. Inscálaithe agus foghlaim dhomhain cruinn le taifid sláinte leictreonacha.<br/>- Lee J, Jun S, Cho Y, Lee H, Kim GB, Seo JB, srl al. Foghlaim dhomhain i Íomháú Leighis: Forbhreathnú Ginearálta ar 2017;18(4): 570 [CrosRef]<br/>- An Roinn Stáit Aontaithe do Ghnóthaí Tréidliachta. Milliún Clár Veteran (MVP) URL: https://www.research.va.gov/mvp/ [rochtain 2019-10-23]<br/>- Patientslikeme. URL: https://www. patientslikeme.com [rochtain 2019-10-23]<br/>- Clár Taighde Uile dúinn. URL: https://allofs.nih.gov [rochtain 2019-10-23]<br/>- Hally A, Norvig P, Pereira F. An éifeachtacht míréasúnta sonraí. IEEE Intel Systemst 2009 Márta;24: 8-12. [CrosRef]<br/>- Angelie D, Kohane IS, Weber GM. Bies i sonraí thaifead sláinte leictreonach mar gheall ar phróisis laistigh den chóras cúraim sláinte: Staidéar breathnóireachta cúlghabhálach. MBJ 30 Aib1479.<br/>- Holzinger A, Langs G, Denk H, Zatloukal K, Müller H. Acmhainn agus inmhínithe ar intleacht shaorga i gcúrsaí leighis.<br/>- Meabhrúchán ríomhaire bunaithe ar Phrótacal-Bhéime, Caighdeán an Cúraim agus Neamh-Fearrbhachas Man. N Eng J Med 1976;295:135355. [CrosRef]<br/>&#124;AAI: intleacht shaorga &#124;<br/>...MULS: United Medical Language System &#124;<br/>curtha in eagar ag G Eyenbach; curtha isteach 15.09.19; piar-athbhreithnithe ag A Holzinger; trácht ar an údar 14.10.19; fuair leagan athbhreithnithe 15.10.19; glacadh leis 20.0.1.19; arna fhoilsiú 27.11.19Cóipcheart<br/>©Qing Zeng-Trijer, Stuart J Nelson. Ar dtús foilsíodh é san Iris um Thaighde Idirlín Leighis (http://www.jmir.org), 27.11.2019.<br/>Is alt oscailte é seo a dháiltear faoi théarmaí an Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), a cheadaíonn úsáid, dáileadh agus atáirgeadh gan srian i meán ar bith, ar choinníoll go luaitear an obair bhunaidh, an chéad fhoilsiú san Iris Taighde ar an Idirlíon Leighis i gceart. Ní mór an t-eolas iomlán bibleagrafach, nasc chuig an bhfoilseachán bunaidh ar http://www.jmir.org/, chomh maith leis an bhfaisnéis cóipchirt agus ceadúnais seo a chur san áireamh. |
| The Story of Selena Quintanilla: A Biography Book for Young Readers (The Story Of: A Biography Series for New Readers) (Paperback)<br/>Most titles are on our shelves or available within 1-5 days.<br/>Discover the life Selena Quintanilla—a story about breaking down barriers in music, for kids ages 6 to 9<br/>Selena Quintanilla was the queen of Tejano music. Before she became a star, Selena was a charismatic young girl who loved singing and performing. She made a lot of sacrifices to become a famous musician, rehearsing her songs and dance moves for hours at a time. Her hard work paid off—she became the first 15-year-old girl to win a Tejano music award and went on to break many records during her career. This Selena biography explores how she went from being a talented girl growing up in Texas to a fashion icon and a world-famous singer.<br/>What sets this Selena book apart:<br/>- Core curriculum—Kids will learn the Who, What, Where, When, Why, and How of Selena’s life, and take a quick quiz to test their knowledge.<br/>- Short chapters—This Selena kids’ book is broken up into brief chapters that make it fun and easy for new readers to discover details about the singer’s life.<br/>- Her lasting legacy—Kids will find out how Selena changed the world of music and why she continues to be a role model for many women and people of color around the globe.<br/>How will Selena’s big spirit and passion for music inspire the child in your life?<br/>About the Author<br/>GLORIA ARJONA teaches Spanish at the California Institute of Technology and is the author of Posadas Unknown Calaveras and ¡Lotería!. She’s also a musician who sings and plays guitar. Learn more at GloriaArjona.com.<br/>“Finally, a Selena book for new readers, one that is told concisely and honestly, and is eminently readable” —Joe Nick Patoski, author of Selena: Como La Flor<br/>“What a wonderful story to inspire girls to follow their dreams. A story that many girls will identify with, especially those from traditional and multicultural families. I liked all the little sidebar lessons throughout the book. Gloria is a very talented teacher.” —Genevieve B. Southgate, director of community programs, Bowers Museum<br/>“Selena Quintanilla’s youthful talent and positive drive are brought to life in Prof. Arjona’s latest book, this one geared to young readers. A highly appealing read highlighting Selena’s flexibility in overcoming obstacles to achieving her dreams and her trailblazing contributions to music and her community. The Callisto Media format of encouraging critical, organized thought via questions, maps, timelines, and a glossary make this an enjoyable learning experience.” —Martin E. Delgado, community library manager<br/>“This is the story of Selena Quintanilla, and what a story it is! In a time where young readers, and young women, need role models more than ever, this book brilliantly depicts the profound humanity, bravery, and talent of a deeply inspiring Latina woman who relentlessly fought for her dream.” —Maite Zubiaurre, UCLA professor | Scéal Selena Quintana: A Beathaisnéis Leabhar na Léitheoirí Óga (An Scéal As: Sraith Beathaisnéis do Léitheoirí Nua) (Papparback)<br/>Tá an chuid is mó de na teidil ar ár seilfeanna nó ar fáil laistigh de 1-5 lá.<br/>Faigh amach faoin saol Selena Quintana. scéal faoi bhriseadh síos bacainní sa cheol, do na páistí 6 go 9<br/>Ba bhanríon ceol Tejano í Selena Quinntailla. Sular tháinig sí chun bheith ina réalta, ba chailín óg í Selena a raibh grá aige don amhránaíocht agus don taibhiú. Rinne sí a lán íobairtí chun bheith ina gceoltóir cáiliúil, ag déanamh taighde ar a hamhráin agus a damhsa ag an am.D’íoc a cuid oibre crua - ba í an chéad chailín 15 bliain d’aois í chun duais ceoil Tejano a bhuachan agus chuaigh sí ar aghaidh chun go leor taifead a bhriseadh le linn a gairme. Scrúdaíonn an beathaisnéis Selena conas a chuaigh sí ó bheith ina cailín cumasach ag fás suas i Texas le deilbhín faisin agus amhránaí a bhfuil cáil dhomhanda uirthi.<br/>An rud a leagann an leabhar seo Selena seachas:<br/>- Bunchúrsa - Foghlaimeoidh páistí an Cé, Cad, Cén áit, Cén fáth, agus Cén chaoi ar shaol Selena, agus tabharfaidh tráth na gceist go tapa chun a gcuid eolais a thástáil.<br/>- caibidlí gearra – Déantar an leabhar seo do pháistí Selena a bhriseadh suas i gcaibidlí gairid a fhágann go bhfuil sé spraoi agus éasca do léitheoirí nua sonraí a fháil amach faoi shaol an t-amhránaí.<br/>- Gheobhaidh a cuid oidhreachta buan - Kids amach conas a d'athraigh Selena saol an cheoil agus cén fáth a leanann sí de bheith ina eiseamláir do go leor mná agus daoine ar fud na cruinne.<br/>Cén chaoi a spreagfaidh spiorad mór agus paisean Selena don cheol an leanbh i do shaol?<br/>Maidir leis an Údar<br/>Múineann GLORIAARJONA Spáinnis ag Institiúid Teicneolaíochta California agus is é údar Posadas Unknown Caleras agus ¡Loteira!.Is ceoltóir í a sheinneann agus a imríonn giotár freisin. Foghlaim níos mó ag GloriaArjona.com.<br/>“Mar fhocal scoir, leabhar Selena do léitheoirí nua, ceann a dúradh go beacht agus go hionraic, agus tá sé go mór inléite” — Joe Nick Patoski, údar Selena: Como La Flor<br/>An scéal iontach a spreagfaidh cailíní chun a n-aisling a leanúint.Sa scéal go n-aithneoidh go leor cailíní leis, go háirithe iad siúd ó theaghlaigh thraidisiúnta agus ilchultúrtha. thaitin mé go léir na ceachtanna beaga ar fud an leabhair. Is múinteoir cumasach í Gloria.”—Geneeve B. Southgate, stiúrthóir na gclár pobail, Bowers Museum<br/>Tugtar an leabhar is déanaí, an ceann seo atá dírithe ar léitheoirí óga, de réir an tseanchais, de chuid Selena Quintana. Léigh an-tarraingteach ag cur béime ar sholúbthacht Selena chun constaicí a shárú chun a cuid aisling agus a cuid buanna maidir le ceol agus a pobal a bhaint amach. Mar gheall ar fhormáid Callito Media chun smaointe criticiúil, eagraithe trí cheisteanna, léarscáileanna, tráthlínte agus gluais, is eispéireas taitneamhach foghlama é seo.”—Martin E. Deglado, bainisteoir leabharlainne pobail<br/>Is é seo an scéal Selena Quintana, agus cad a scéal é! In am inar gá do léitheoirí óga, agus do mhná óga, róil a bheith acu níos mó ná riamh, léiríonn an leabhar seo an chine daonna, crógacht, agus tallann bean dhomhain spreagúil Latina a throid gan staonadh as a aisling.” — Maite Zubure, ollamh UCLA |
| Here's another reason for men to avoid packing on extra pounds over the holidays: A new study has found that losing weight reduces the risk of an aggressive form of prostate cancer.<br/>After tracking the weight of nearly 70,000 men between 1982 and 1992, researchers from the American Cancer Society and the Duke University Prostate Center found that men who lost more than 11 pounds had a lower risk for aggressive prostate cancer than men whose weight remained the same over a decade.<br/>Previous studies have found that obese men have a higher risk of developing aggressive prostate cancer. This study appears to be the first to indicate that recent weight loss can decrease that risk.<br/>In the study reported this month in Cancer Epidemiology, Biomarkers & Prevention, researchers analyzed the height and weight of the men in 1982 and 1992 and every three years after that until 2003. At that time, more than 5,200 of the men — more than 7 percent — had prostate cancer.<br/>Among those cases, about one in eight had a form of cancer that was aggressive but had not spread to other areas of the body. The study's major finding focused on those aggressive cases, with researchers concluding that those who lost 11 or more pounds were 42 percent less likely to develop that form of prostate cancer than those whose weight remained the same.<br/>"Whether it's exactly 40 percent, we don't know, but they lower their risk when they lose 11-plus pounds. We feel confident, at least in this population, that was real," said lead researcher Dr. Carmen Rodriguez.<br/>More than seven times as many men whose weight remained the same developed aggressive prostate cancer compared to those who lost 11 or more pounds.<br/>"No significant associations" were found regarding the effect of weight gain or loss on the most severe forms of prostate cancer, those that spread throughout the body, the study said.<br/>The number studied was small, the researchers acknowledged, because fewer than 15,000 men lost weight over the time period, and only 1,000 of those developed some form of prostate cancer.<br/>The 69,991 participants were part of a bigger cancer society study of 1.2 million Americans that began in 1982.<br/>Rodriguez said men should avoid putting on extra weight as they get older.<br/>"The main message for men is to not get overweight. If they are overweight, that's another reason to try to lose weight, just to decrease the risk for prostate cancer," said Rodriguez, who works for the Atlanta-based cancer society.<br/>Other than skin cancer, prostate cancer is the most commonly diagnosed cancer for men, and about one in six will get it during his lifetime. It is the second leading cause of cancer death for U.S. men.<br/>The study is considered the first of its kind to examine the role of weight change in the development of prostate cancer, said Dr. Ronald Ennis, director of radiation oncology at St. Luke's-Roosevelt Hospital Center in New York, who was not involved in the study.<br/>"This is one of the best studies" examining the role of weight on prostate cancer, Ennis said. "It does seem to be true that if you are overweight, you are at risk of getting more aggressive forms of prostate cancer and if you lose weight, you can decrease the risk." | Seo cúis eile d’fhir pacáil ar punt breise thar na laethanta saoire a sheachaint: Fuair staidéar nua amach go laghdaíonn meáchan an baol go dtarlóidh ailse próstatach.<br/>Tar éis meáchan beagnach 70,000 fear a rianú idir 1982 agus 1992, fuair taighdeoirí ó Chumann Ailse Mheiriceá agus ó Ionad Próstatach Ollscoile Diúc go raibh riosca níos ísle ag fir a chaill níos mó ná 11 punt maidir le hailse próstatach ionsaitheach ná mar a d’fhan a mheáchan mar an gcéanna thar deich mbliana.<br/>Thángthas ar staidéir roimhe seo go bhfuil baol níos airde ag fir murtallach ailse phróstatach ionsaitheach a fhorbairt.Is cosúil gurb é an staidéar seo an chéad rud a léiríonn gur féidir le meáchain caillteanas a laghdú le déanaí an riosca sin.<br/>Sa staidéar, thuairiscigh na taighdeoirí airde agus meáchan na bhfear i 1982 agus 1992 agus gach trí bliana ina dhiaidh sin go dtí 2003. Ag an am sin, bhí níos mó ná 5,200 de na fir — níos mó ná 7 faoin gcéad — ailse phróstatach.<br/>I measc na gcásanna sin, bhí cineál ailse ag thart ar dhuine in ocht gcinn ach níor scaipeadh go réimsí eile den chorp iad. Is lú an seans go bhforbródh an chuid is mó den staidéar, arna dhíriú ar na cásanna ionsaitheach sin, le taighdeoirí a thugann i gcrích gur lú an seans go bhforbródh siad an cineál ailse próstatach ná na cinn a raibh a mheáchan mar an gcéanna.<br/>Cibé an bhfuil sé go díreach 40 faoin gcéad, níl a fhios againn, ach laghdaíonn siad a riosca nuair a chailleann siad punt amhail 11-móide.Braitheann muid muiníneach, ar a laghad sa daonra, go raibh fíor," a dúirt taighdeoir luaidhe Dr Carmen Rodriguez.<br/>Níos mó ná seacht n-uaire an oiread fir a d’fhan a mheáchan an ailse próstatach ionsaitheach céanna i gcomparáid leo siúd a chaill 11 punt nó níos mó.<br/>Fuarthas amach "Níl aon chumann suntasach" maidir leis an éifeacht a fháil ar mheáchan nó caillteanas ar na foirmeacha is déine de ailse próstatach, iad siúd a scaipeadh ar fud an chomhlachta, dúirt an staidéar.<br/>Ba bheag an líon a ndearnadh staidéar air, d’aithin na taighdeoirí, mar chaill níos lú ná 15,000 fear meáchan thar an tréimhse ama, agus ní raibh ach 1,000 díobh sin a d’fhorbair cuid de ailse phróstatach.<br/>Bhí rannpháirtithe 69991 mar chuid de staidéar sochaí ailse níos mó ar 1.2 milliún Meiriceánach a thosaigh i 1982.<br/>Dúirt Rodriguez gur chóir d'fhir a sheachaint a chur ar meáchan breise mar a fhaigheann siad níos sine.<br/>Más rud é go bhfuil siad róthrom, is cúis eile chun meáchan a chailleadh, díreach chun an riosca a bhaineann le hailse próstatach a laghdú," a dúirt Rodriguez, a oibríonn do shochaí ailse atá lonnaithe in Atlanta.<br/>Seachas ailse craicinn, is é ailse próstatach an ailse is coitianta a diagnóisíodh d'fhir, agus gheobhaidh thart ar cheann i sé cinn é le linn a shaoil.Is é an dara cúis a bhaineann le bás ailse d'fhir na Stát Aontaithe.<br/>Meastar go bhfuil an staidéar ar an gcéad chineál chun scrúdú a dhéanamh ar ról an athraithe meáchain i bhforbairt ailse phróstatach, a dúirt an Dr Ronald Ennis, stiúrthóir an oinceolaíochta radaíochta ag Ionad Ospidéal Naomh Lúcás-Roosevelt i Nua-Eabhrac, nach raibh baint aige leis an staidéar.<br/>Tá sé seo ar cheann de na staidéir is fearr’ a dhéanann iniúchadh ar ról an mheáchain maidir le hailse próstatach, a dúirt Inis. "Ní cosúil go bhfuil sé fíor go bhfuil tú róthrom, tá an baol ann go bhfaighidh tú foirmeacha níos ionsaitheach ailse próstatach agus má chailleann tú meáchan, is féidir leat an riosca a laghdú." |
| If you have studied the OSI model with its 7 Layers that describe communication on computer network systems, you should know that the Ethernet standard lies in Layer 1 (Physical) and Layer 2 (Data-Link) of the OSI model.<br/>In this article we will focus on the physical (Layer 1) part of Ethernet, which mainly focuses on the wired physical medium (cabling) that is used to transport Ethernet frames in a network.<br/>Ethernet cables connect devices to computer networks, the “heart” of which is usually an Ethernet switch which has several interface ports for “plugging-in” the cables.<br/>Most of these Ethernet cables feature the standard RJ45 connector for plugging-in to a switch. However, Ethernet communication can be implemented also using Fiber-optic cabling which uses different types of connectors.<br/>Moreover, there are different types of Ethernet cables with varying bandwidths, speeds and types of construction. In this article we will discuss the “copper-made” cables which are the most popular ones in computer networks.<br/>The cables have labels indicating the standard used for manufacturing, ranging from category (cat) 3 to 7.<br/>Ethernet cables consist of several (usually 8) smaller wires (inside the main cable) which are separated in Twisted-pairs. This setup helps in cancelling-out electromagnetic interference between wires, thus allowing signals to travel longer distances inside the wires.<br/>Without the right cable (and of course without the right type of switch), you may experience slower speeds in the network between devices.<br/>Let’s now describe each Category of Ethernet Cables with their characteristics:<br/>&#124;Max Length&#124;&#124;100 m&#124;&#124;100 m&#124;&#124;100 m&#124;&#124;100 m<br/>(55 m for 10Gbps)<br/>&#124;100 m&#124;&#124;100 m&#124;<br/>&#124;Max Speed&#124;&#124;10 Mbps&#124;&#124;100 Mbps&#124;&#124;1 Gbps&#124;&#124;10 Gbps&#124;&#124;10 Gbps&#124;&#124;>10 Gbps&#124;<br/>&#124;Frequency Bandwidth&#124;&#124;16 MHz&#124;&#124;100 MHz&#124;&#124;100 MHz&#124;&#124;250 MHz&#124;&#124;500 MHz&#124;&#124;600 MHz&#124;<br/>&#124;Shielded / Unshielded&#124;&#124;Unshielded&#124;&#124;Unshielded&#124;&#124;Unshielded&#124;&#124;Shielded or Unshielded&#124;&#124;Shielded&#124;&#124;Shielded&#124;<br/>1) Cat 3<br/>One of the oldest Ethernet cabling standards is category (cat) 3 (TIA/EIA-568-B). These cables allowed 10 Mbps transmission speeds with 16 MHz max bandwidth.<br/>Cat 3 ethernet cables feature unshielded twisted pair (UTP) cabling. With UTP cables, manufacturers twist insulated copper wires together inside a polyethylene jacket. Compared to shielded ethernet cables, UTP cables tend to include more crosstalk.<br/>Network connections commonly featured category 3 ethernet cables until the early 1990s, when category 5 cables replaced cat 3. While some older telephone systems may still use cat 3 cables, they have mostly become obsolete in the networking industry.<br/>2) Cat 5<br/>Cat 5 cables increased the bandwidth of Ethernet connections up to 100 MHz and offered transmission speeds up to 100 Mbps. With Cat 5 ethernet cables, users could access 100BASE-TX ethernet systems, referred to as fast ethernet.<br/>As with the category 3 cables, cat 5 cables still feature crosstalk and interference, due to the UTP design. These cables include four pairs of twisted wires (for a total of 8 wires).<br/>While cat 5 cables primarily provide connections for Ethernet applications, these cables also provide solutions for carrying other data signals, such as video and telephone. In fact, a single cat 5 cable can carry two standard phone lines and a 100BASE-TX connection.<br/>3) Cat 5e<br/>In 2001, the category 5e standard replaced category 5. The letter “e” in the name stands for enhanced.<br/>The cabling still uses unshielded twisted pairs. There are no physical differences between cat 5 and cat 5e cables. However, stricter standards in manufacturing Cat5e cables help minimize crosstalk and allow higher data transmissions than Cat5.<br/>Cat 5e cables also utilize two sets of twisted pairs of wires, resulting in faster speeds. While cat 5e ethernet cable still features 100 MHz bandwidth, these cables allow speeds up to 1000 Mbps (1 Gbps).<br/>While several additional standards have come after cat 5e, these cables remain in production. In fact, due to the lower cost of production and support for gigabit ethernet, cat 5e cables are the most used for network applications throughout the world.<br/>4) Cat 6<br/>Cat 6 ethernet cables helped address issues related to interference and crosstalk. These cables use thinner wires and superior insulation, resulting in a better signal-to-noise ratio.<br/>With these features, cat 6 cables provide a more effective option for adding cable in areas with more electromagnetic interference, such as a crowded server room.<br/>Thanks to the superior design, cat 6 provides improved bandwidth. These cables have a max bandwidth of 250 MHz and max transmission speeds up to 1000 Mbps (1 Gbps) at the 100m range. However, 10Gbps can be achieved in Cat6 in smaller distances (up to 55m).<br/>Some cat 6 cables include shielding while others remain unshielded. With shielding, these cables can provide transmission speeds up to 10 Gbps, but only for short distances as we said above.<br/>5) Cat 6a<br/>Category 6a ethernet cables improve the design of the cat 6 cables. The letter “a” stands for augmented. Unlike cat 6 cables, all cat 6a cables feature shielded cabling for reduced interference.<br/>With the enhancements to the design specifications, cat 6a cables maintain higher transmission speeds and 500 MHz max bandwidth, allowing speeds up to 10000 Mbps (10 Gbps) across longer cables.<br/>While these cables provide faster speeds, the design makes them less flexible. To eliminate crosstalk, these cables feature thicker sheathing, making the cables stiffer and more difficult to work.<br/>6) Cat 7<br/>One of the latest developments is Cat 7 Ethernet cables. Also called class F channel cables, these cables include stricter standards compared to previous categories. The individual wire pairs now include their own shielding, in addition to the outer shielding<br/>With these cables, you get 600 MHz max bandwidth and 10000 Mbps (10 Gbps) transmission speeds. However, by almost completely getting rid of crosstalk, cat 7 ethernet cables offer even greater reliability for 10 Gbps Ethernet connections.<br/>With connections less than 15 meters, cat 7 can support transmission speeds up to 100 Gbps. While the industry has released several new standards since cat 7, these cables are currently the top of the line option for demanding networking applications.<br/>- What is OSPF NSSA (Not So Stubby Area) and How is it Configured?<br/>- Comparison of BOOTP vs DHCP Protocols in Computer Networks<br/>- Pros and Cons of SD-WAN in Networks – Description and Discussion<br/>- Comparison of GNS3 vs EVE-NG vs Packet Tracer for Networks Simulation<br/>- Subnetting vs Supernetting – What’s the Difference? (Explanation Guide) | Má rinne tú staidéar ar an tsamhail OSI lena 7 Sraith a chuireann síos ar chumarsáid ar chórais líonra ríomhaireachta, ba chóir go mbeadh a fhios agat go bhfuil caighdeán Ethernet i Sraith 1 (Phisical) agus Sraith 2 (Data-Link) den tsamhail OSI.<br/>San Airteagal seo, díreoimid ar an gcuid fhisiceach (Ciseal 1) de Ethernet, a dhíríonn go príomha ar an meán fisiceach sreangaithe (cáblaáil) a úsáidtear chun frámaí Ethernet a iompar i líonra.<br/>Ceanglaíonn cáblaí Ethernet feistí le líonraí ríomhaireachta, agus is gnách gurb é “croí” díobh lasc Ethernet a bhfuil roinnt calafoirt comhéadain aige le haghaidh "plugging-in" na cáblaí.<br/>Tá an cónascaire RJ45 caighdeánach ag an gcuid is mó de na cáblaí Ethernet seo le haghaidh breiseán isteach le lasc.Mar sin féin, is féidir cumarsáid Ethernet a chur i bhfeidhm freisin ag baint úsáide as cábla Snáithín snáthoptaice a úsáideann cineálacha éagsúla nascóirí.<br/>Ina theannta sin, tá cineálacha éagsúla cáblaí Ethernet le bandaleithead éagsúla, luasanna agus cineálacha tógála.San Airteagal seo déanfaimid plé ar na cáblaí “comhdhéanta” arb iad na cinn is coitianta iad i líonraí ríomhaireachta.<br/>Tá lipéid ar na cáblaí a léiríonn an caighdeán a úsáidtear le haghaidh déantúsaíochta, ó chatagóir (cat) 3 go 7.<br/>Is éard atá i gcáblaí Ethernet de roinnt sreanga níos lú (de ghnáth 8) atá scartha i mbeirteanna Twisted. Cuidíonn an socrú seo le cur isteach leictreamaighnéadach a chealú idir sreanga, rud a ligeann do chomharthaí achair níos faide a taisteal taobh istigh de na sreanga.<br/>Gan an cábla ceart (agus ar ndóigh gan an cineál ceart lasc), is féidir leat taithí luasanna níos moille sa líonra idir feistí.<br/>Déanaimis cur síos anois ar gach catagóir Cáblaí Ethernet lena saintréithe:<br/>&#124; Fad Max &#124; 100 m&#124;100 m&#124;100 m&#124;100 m&#124;&#124;100 m&#124;100 m<br/>(55 m ar feadh 10Gbps)<br/>&#124; 100 m &#124; 100 m &#124;<br/>&#124; Luas Max &#124;10 Mbps &#124; 100 Mbps &#124;1 Gbps &#124;10 Gbps &#124; &#124;10 Gbps &#124;>10 Gbps &#124;<br/>&#124; Bandaleithid na minicíochta &#124;16 MHz &#124; 100 MHz &#124; 100 MHz &#124; 250 MHz &#124; 500 MHz &#124; 600 MHz &#124;<br/>&#124; Sciath / Neamhshealbhaithe &#124;&#124;&#124;Malairí &#124;&#124;&#124;&#124;Sciathraithe &#124;&#124;Sciathaithe nó Neamh-Shaoil &#124;&#124;Shaoil &#124;&#124;Shaoil &#124; &#124;&#124;&#124;Shaoil &#124; &#124; &#124; &#124;<br/>1) Cat 3<br/>Ceann de na caighdeáin cábla Ethernet is sine catagóir (cat) 3 (TIA/EI-568-B). Ceadaítear na cáblaí seo 10 Mbps tarchur le 16 MHz bandaleithead uasta.<br/>I measc na gcáblaí ethernet Cat 3 tá cáblaáilte gan sreang (UTP).Le cáblaí UTP, déanann monaróirí sreanga copair inslithe le chéile taobh istigh de seaicéad poileitiléin.I gcomparáid le cáblaí ethernet sciath, bíonn claonadh ag cáblaí UTP níos mó crosstalk a áireamh.<br/>Naisc Líonra le feiceáil go coitianta catagóir 3 cáblaí ethernet go dtí go luath sna 1990í, nuair a tháinig catagóir 5 cáblaí in ionad cat 3. Cé go bhféadfadh roinnt córais teileafóin níos sine a úsáid fós cat 3 cáblaí, tá siad den chuid is mó imithe i léig sa tionscal líonraithe.<br/>2) Cat 5<br/>Mhéadaigh cábla Cat 5 bandaleithead Ethernet naisc suas le 100 MHz agus thairg luasanna tarchurtha suas le 100 Mbps.Le cáblaí Ethernet Cat 5, d'fhéadfadh úsáideoirí rochtain a fháil ar chórais ethernet 100BASE-TX, dá ngairtear ethernet go tapa.<br/>Mar aon leis an gcatagóir 3 cáblaí, tá crosstalk agus cur isteach fós ar 5 cáblaí, mar gheall ar an dearadh UTP.Áirítear leis na cáblaí seo ceithre phéire sreanga casta (i gcás sreang 8 san iomlán).<br/>Cé go soláthraíonn cáblaí cat 5 naisc go príomha le haghaidh feidhmchlár Ethernet, soláthraíonn na cáblaí seo réitigh freisin chun comharthaí sonraí eile a iompar, mar fhíseán agus teileafón. Déanta na fírinne, is féidir le cábla cat amháin dhá líne teileafóin chaighdeánacha agus nasc 100BASE-TX a iompar.<br/>3) Cat 5e<br/>Sa bhliain 2001, tháinig an chatagóir 5e in ionad an chatagóir 5. Tá an litir “e” in ainm níos fearr.<br/>Ní bhíonn aon difríochtaí fisiciúla idir cáblaí cat 5 agus cat 5e fós ag an gcábla. Mar sin féin, cabhraíonn caighdeáin níos déine i ndéantúsaíocht cáblaí Cat5e le trasrian sonraí níos airde a íoslaghdú agus cuireann siad ar chumas tarchur sonraí níos airde ná Cat5.<br/>Úsáideann cáblaí Cat 5e dhá thacar de shreangacha, agus luasanna níos tapúla dá bharr sin.Cé go bhfuil bandaleithead 100 MHz fós ag cábla cat 5e, ceadaíonn na cáblaí seo suas le 1000 Mbps (1Gbps).<br/>Cé go bhfuil roinnt caighdeáin bhreise tagtha tar éis cat 5e, fanann na cáblaí seo i dtáirgeadh.Go deimhin, mar gheall ar an gcostas táirgthe is ísle agus an tacaíocht le haghaidh ethernet gigabit, is iad cáblaí cat 5e an ceann is mó a úsáidtear le haghaidh iarratais líonra ar fud an domhain.<br/>4) Cat 6<br/>Chabhraigh Cat 6 cáblaí ethernet le dul i ngleic le saincheisteanna a bhaineann le cur isteach agus crosstalk.Úsáideann na cáblaí seo sreanga níos tanaí agus insliú níos fearr, rud a fhágann go bhfuil cóimheas comhartha-go-torann níos fearr.<br/>Leis na gnéithe seo, soláthraíonn cáblaí cat 6 rogha níos éifeachtaí chun cábla a chur leis i gceantair le cur isteach níos leictreamaighnéadacha, mar shampla seomra freastalaí plódaithe.<br/>A bhuíochas leis an dearadh níos fearr, soláthraíonn cat 6 bandaleithead níos fearr.Tá bandaleithead uasta 250 MHz agus uasluas tarchurtha ag na cáblaí seo suas go dtí 1000 Mbps (1Gbps) ag an raon 100m. Mar sin féin, is féidir 10Gbps a bhaint amach i Cat6 i achair níos lú (suas go dtí 55m).<br/>I measc roinnt cáblaí cat 6 tá sciath cé go bhfanann daoine eile gan réiteach.Le sciath, is féidir leis na cáblaí seo luasanna tarchurtha a sholáthar suas le 10 nGbps, ach amháin le haghaidh achair ghearr mar a dúirt muid thuas.<br/>5) Cat 6a<br/>Catagóir 6a cáblaí ethernet feabhas a chur ar dhearadh na gcáblaí cat 6.Seasann an litir “a” le haghaidh méadaithe.Murab ionann agus cáblaí cat 6a, gnéíonn na cáblaí cat go léir cáblaí 6a cábla sciath le haghaidh cur isteach laghdaithe.<br/>Leis na feabhsuithe ar na sonraíochtaí dearaidh, coinníonn cáblaí cat 6a luasanna tarchurtha níos airde agus 500 MHz bandaleithead uasta, rud a ligeann do luasanna suas le 10000 Mbps (Gbps) thar cháblaí níos faide.<br/>Cé go soláthraíonn na cáblaí seo luasanna níos tapúla, déanann an dearadh iad níos solúbtha.Chun deireadh a chur le crosstalk, tá scáthú níos tiús ag na cáblaí seo, rud a fhágann go bhfuil na cáblaí níos déine agus níos deacra a bheith ag obair.<br/>6) Cat 7<br/>Is é ceann de na forbairtí is déanaí ná cáblaí Cat 7 Ethernet. Chomh maith leis sin ar a dtugtar cáblaí cainéal F, cuimsíonn na cáblaí seo caighdeáin níos déine i gcomparáid le catagóirí roimhe seo. Áirítear ar na péirí sreang aonair a sciath féin anois, chomh maith leis an sciath seachtrach<br/>Leis na cáblaí seo, gheobhaidh tú 600 MHz bandaleithead uasta agus 10000 Mbps (Gbps) luasanna tarchurtha.Mar sin féin, ag fáil réidh go hiomlán le crosstalk, cat 7 cáblaí ethernet níos mó iontaofachta le haghaidh 10 nGbps Ethernet naisc.<br/>Le naisc níos lú ná 15 méadar, is féidir le cat 7 tacú le luasanna tarchurtha suas le 100 Gbps.Cé go bhfuil roinnt caighdeáin nua eisithe ag an tionscal ó cat 7, is iad na cáblaí seo an rogha líne is fearr chun iarratais líonraithe a éileamh faoi láthair.<br/>- Cad é SNSSA OFPF (Níl Sin Scuby Area) agus Conas a dhéantar é a chumrú?<br/>- Comparáid idir BOOTP vs DHCP Prótacail i líonraí Ríomhaireachta<br/>- Buntáistí agus Míbhuntáistí SD-WAN i Líonraí – Cur síos agus Plé<br/>- Comparáid idir GNS3 vs GACH-NG vs Rianaire Paicéad le haghaidh Líonraí Insamhladh<br/>- Subtting vs Superetting – Cad é an Difríocht? (Treoir Míniú) |
| Views: 4 Author: Site Editor Publish Time: 2022-06-09 Origin: Site<br/>So why should workers wear a portable gas detector and what does it do?<br/>In many industrial environments, workers need to be highly aware of exposure to toxic or combustible gases and vapours or a lack of oxygen. That’s why portable gas detectors and analysers are essential – so they can detect, measure, monitor and react to any gases in the immediate area around them. KELISAIKE SAFETY offers both single- and multi-gas mobile gas monitors that reliably detect a wide range of gases. All of our portable gas detectors and software are designed to make compliance and asset management as intuitive as possible, so you can implement a complete product solution that helps ensure safety at all times.<br/>Portable gas detectors are classed as a type of Personal Protective Equipment (PPE)<br/>They monitor gases in the workers breathing zone by displaying real-time gas levels of a variety of toxic, combustible, flammable gases<br/>They alert the worker of any possible threats which include combustion and oxygen displacement<br/>While portable gas detectors are available with various sensor configurations and features, they are all built with the same purpose - to protect human life! | Radhairc: 4 Údar: Site Editor Time Foilsitheoir: 2022-06-09 Bunús: Suíomh<br/>Mar sin, cén fáth ar chóir d'oibrithe brathadóir gáis iniompartha a chaitheamh agus cad a dhéanann sé?<br/>I go leor timpeallachtaí tionsclaíocha, ní mór d’oibrithe a bheith ar an eolas go mór faoi nochtadh do gháis tocsaineacha nó indóite nó easpa ocsaigine. Sin an fáth go bhfuil brathadóirí agus anailíseoirí iniompartha riachtanach - ionas gur féidir leo aon ghás sa limistéar láithreach timpeall orthu a bhrath, a thomhas, monatóireacht a dhéanamh orthu agus freagairt dóibh. Cuireann SÁBHÁILTEACHT SKY monatóirí gáis soghluaiste aon-agus ilgháis ar fáil a bhraitheann raon leathan gás go hiontaofa. Tá ár brathadóirí agus bogearraí iniompartha go léir deartha chun bainistíocht chomhlíonta agus sócmhainní a dhéanamh chomh iomasach agus is féidir, ionas gur féidir leat réiteach iomlán táirge a chur i bhfeidhm a chabhraíonn le sábháilteacht a chinntiú i gcónaí.<br/>Tá brathadóirí iniompartha gáis aicmithe mar chineál Trealamh Cosanta Pearsanta (PPE)<br/>Déanann siad faireachán ar gháis i gcrios análaithe na n-oibrithe trí leibhéil gáis fíor-ama d’éagsúlacht gás tocsaineacha, indóite, inadhainte a thaispeáint<br/>Tugann siad foláireamh d’oibrí aon bhagairtí féideartha lena n-áirítear dócháin agus díláithriú ocsaigine<br/>Cé go bhfuil brathadóirí gáis iniompartha ar fáil le cumraíochtaí agus gnéithe braiteora éagsúla, tógtar iad go léir leis an gcuspóir céanna - chun saol an duine a chosaint! |
